Cargando…

Remuscularization with triiodothyronine and β(1)-blocker therapy reverses post-ischemic left ventricular dysfunction and adverse remodeling

Renewal of the myocardium by preexisting cardiomyocytes is a powerful strategy for restoring the architecture and function of hearts injured by myocardial infarction. To advance this strategy, we show that combining two clinically approved drugs, but neither alone, muscularizes the heart through car...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bogush, Nikolay, Tan, Lin, Naqvi, Emmen, Calvert, John W., Graham, Robert M., Taylor, W. Robert, Naqvi, Nawazish, Husain, Ahsan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132945/ https://www.ncbi.nlm.nih.gov/pubmed/35614155 http://dx.doi.org/10.1038/s41598-022-12723-2

Ejemplares similares

Thyroid hormone plus dual-specificity phosphatase-5 siRNA increases the number of cardiac muscle cells and improves left ventricular contractile function in chronic doxorubicin-injured hearts
por: Tan, Lin, et al.
Publicado: (2021)

Redox activation of JNK2α2 mediates thyroid hormone-stimulated proliferation of neonatal murine cardiomyocytes
por: Tan, Lin, et al.
Publicado: (2019)

DUSP5 expression in left ventricular cardiomyocytes of young hearts regulates thyroid hormone (T3)-induced proliferative ERK1/2 signaling
por: Bogush, Nikolay, et al.
Publicado: (2020)

Comparative regenerative mechanisms across different mammalian tissues
por: Iismaa, Siiri E., et al.
Publicado: (2018)

Mechanism-Based Cardiac Regeneration Strategies in Mammals
por: Naqvi, Nawazish, et al.
Publicado: (2021)

Impact of Lymphangiogenesis on Cardiac Remodeling After Ischemia and Reperfusion Injury
por: Shimizu, Yuuki, et al.
Publicado: (2018)

Pluripotent stem cell-derived committed cardiac progenitors remuscularize damaged ischemic hearts and improve their function in pigs
por: Yap, Lynn, et al.
Publicado: (2023)

Large animal models for cardiac remuscularization studies: A methodological review
por: Yu, Yuexin, et al.
Publicado: (2023)

Role of DJ‐1 in Modulating Glycative Stress in Heart Failure
por: Shimizu, Yuuki, et al.
Publicado: (2020)

Human Engineered Heart Tissue Patches Remuscularize the Injured Heart in a Dose-Dependent Manner
por: Querdel, Eva, et al.
Publicado: (2021)

Pressure overload by suprarenal aortic constriction in mice leads to left ventricular hypertrophy without c-Kit expression in cardiomyocytes
por: Nicks, Amy M., et al.
Publicado: (2020)

Adverse transverse-tubule remodeling in a rat model of heart failure is attenuated with low-dose triiodothyronine treatment
por: An, Shimin, et al.
Publicado: (2019)

Measurement of Reverse Triiodothyronine Level and the Triiodothyronine to Reverse Triiodothyronine Ratio in Dried Blood Spot Samples at Birth May Facilitate Early Detection of Monocarboxylate Transporter 8 Deficiency
por: Iwayama, Hideyuki, et al.
Publicado: (2021)

Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke
por: Mdzinarishvili, Alexander, et al.
Publicado: (2012)

Exercise training provides cardioprotection by activating and coupling endothelial nitric oxide synthase via a β(3)-adrenergic receptor-AMP-activated protein kinase signaling pathway
por: Barr, Larry A., et al.
Publicado: (2017)

Cardiac hypertrophy limits infarct expansion after myocardial infarction in mice
por: Iismaa, Siiri E., et al.
Publicado: (2018)

Free Triiodothyronine Is Associated with Poor Outcomes after Acute Ischemic Stroke
por: Song, Yue, et al.
Publicado: (2022)

Impact of correction of ischemic mitral valve on left ventricular reverse remodeling
por: Nikolic, A, et al.
Publicado: (2013)

Development of Triiodothyronine Polymeric Nanoparticles for Targeted Delivery in the Cardioprotection against Ischemic Insult
por: Karakus, Ozlem Ozen, et al.
Publicado: (2021)

MAGGIC Risk Model Predicts Adverse Events and Left Ventricular Remodeling in Non-Ischemic Dilated Cardiomyopathy
por: Dong, Yang, et al.
Publicado: (2020)

Left Ventricular Adverse Remodeling in Ischemic Heart Disease: Emerging Cardiac Magnetic Resonance Imaging Biomarkers
por: Calvieri, Camilla, et al.
Publicado: (2023)

A Large-Scale Investigation of Hypoxia-Preconditioned Allogeneic Mesenchymal Stem Cells for Myocardial Repair in Nonhuman Primates: Paracrine Activity Without Remuscularization
por: Hu, Xinyang, et al.
Publicado: (2016)

Is green investment different from grey? Return and volatility spillovers between green and grey energy ETFs
por: Rizvi, Syed Kumail Abbas, et al.
Publicado: (2021)

Mitochondria as Key Targets of Cardioprotection in Cardiac Ischemic Disease: Role of Thyroid Hormone Triiodothyronine
por: Forini, Francesca, et al.
Publicado: (2015)

Characterization of heart failure patients with reverse left ventricular remodelling post‐angiotensin receptor blockers/neprilysin inhibitors therapy
por: Maizels, Leonid, et al.
Publicado: (2022)

Beta‐Blocker Use Is Associated With Prevention of Left Ventricular Remodeling in Recovered Dilated Cardiomyopathy
por: Enzan, Nobuyuki, et al.
Publicado: (2021)

Prediction of left ventricular reverse remodeling after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy
por: Matsumura, Yoshihisa, et al.
Publicado: (2015)

Effect of triiodothyronine on hyperandrogenism in women
por: Kazanavicius, Gintautas, et al.
Publicado: (2013)

Diagnostic Values of Free Triiodothyronine and Free Thyroxine and the Ratio of Free Triiodothyronine to Free Thyroxine in Thyrotoxicosis
por: Chen, Xinxin, et al.
Publicado: (2018)

Triiodothyronine Acts as a Smart Influencer on Hsp90 via a Triiodothyronine Binding Site
por: Fan, Lu, et al.
Publicado: (2022)

Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy
por: Díez-López, Carles, et al.
Publicado: (2022)

Beneficial effects of an angiotensin-II receptor blocker on structural atrial reverse-remodeling in a rat model of ischemic heart failure
por: YOON, NAMSIK, et al.
Publicado: (2013)

The impact of a dose of the angiotensin receptor blocker valsartan on post‐myocardial infarction ventricular remodelling
por: Park, Kyungil, et al.
Publicado: (2018)

Covid-19 and asset management in EU: a preliminary assessment of performance and investment styles
por: Rizvi, Syed Kumail Abbas, et al.
Publicado: (2020)

Price reaction, volatility timing and funds’ performance during Covid-19
por: Mirza, Nawazish, et al.
Publicado: (2020)

Impact of Covid-19 on corporate solvency and possible policy responses in the EU
por: Mirza, Nawazish, et al.
Publicado: (2023)

The impact of COVID-19 on the valuations of non-financial European firms
por: Abbas Rizvi, Syed Kumail, et al.
Publicado: (2022)

Endothelin Receptor Blocker Reverses Breast Cancer–Induced Cardiac Remodeling
por: Maayah, Zaid H., et al.
Publicado: (2023)

Molecular Basis for the Remarkably Different Gas-Phase Behavior of Deprotonated Thyroid Hormones Triiodothyronine (T3) and Reverse Triiodothyronine (rT3): A Clue for Their Discrimination?
por: Corinti, Davide, et al.
Publicado: (2021)

Thyroid Function, Reverse Triiodothyronine, and Mortality in Critically Ill Clinical Patients
por: da Silveira, Carlos DG, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r375kfqculp63u3p4eggm276ie